(Q47722222)

5 February 2018

title

Decreased expression of osteopontin is related to tumor aggressiveness and clinical outcome of intrahepatic cholangiocarcinoma (English)

1 reference

5 February 2018

0 references

4

Yoshiki Asayama

1 reference

5 February 2018

author name string

Takahiro Terashi

1

1 reference

5 February 2018

Shinichi Aishima

2

1 reference

5 February 2018

Kenichi Taguchi

3

1 reference

5 February 2018

Keishi Sugimachi

5

1 reference

5 February 2018

Shuji Matsuura

6

1 reference

5 February 2018

Mitsuo Shimada

7

1 reference

5 February 2018

Shinichiro Maehara

8

1 reference

5 February 2018

Yoshihiko Maehara

9

1 reference

5 February 2018

Masazumi Tsuneyoshi

10

1 reference

5 February 2018

publication date

1 February 2004

1 reference

5 February 2018

published in

Liver International

1 reference

5 February 2018

volume

24

1 reference

5 February 2018

issue

1

1 reference

5 February 2018

page(s)

38-45

1 reference

5 February 2018

Role of osteopontin in cellular signaling and toxicant injury

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.00886.X

The metastasis gene osteopontin: a candidate target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.00886.X

Overexpression of osteopontin in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.00886.X

Expression of osteopontin and osteonectin in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.00886.X

Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.00886.X

Differential osteopontin expression in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.00886.X

Quantitative measurement of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level in gastric cancer by real-time RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.00886.X

The role of overexpression and gene amplification of cyclin D1 in intrahepatic cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.00886.X

c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.00886.X

The LCC15-MB human breast cancer cell line expresses osteopontin and exhibits an invasive and metastatic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.00886.X

Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.00886.X

Interleukin-12 as an adjuvant for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.00886.X

10.1111/J.1478-3231.2004.00886.X

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

15101999

1 reference

5 February 2018